triolein
Small moleculeexperimental
Triolein is a symmetrical triglyceride derived from glycerol and three units of the unsaturated fatty acid oleic acid. Most triglycerides are unsymmetrical, being derived from mixtures of fatty acids. Triolein represents 4–30% of olive oil. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 1998 (NCT00004418)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTriolein ↗
Also known as
- glyceryl trioleate
- glyceryl trioleate
- glyceryl trioleate
- triolein
- triolein
- triolein
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03002168 | N/A | Jan 1, 2017 | Mayo Clinic, SFI Research |
| NCT00004450 | N/A | Aug 1, 1998 | Food and Drug Administration, Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
| NCT00004418 | Phase 2/Phase 3 (Phase 3) | Apr 1, 1998 | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Academic/Hospital | 2 | 1 | 2 | 1998 |
| Food and Drug Administration | Government | 1 | 1 | 1 | 1998 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2017 |
| SFI Research | Academic/Hospital | 1 | 0 | 1 | 2017 |
4 organizations
Page 1 / 1